421 related articles for article (PubMed ID: 28515341)
1. BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.
Duan Q; McMahon S; Anand P; Shah H; Thomas S; Salunga HT; Huang Y; Zhang R; Sahadevan A; Lemieux ME; Brown JD; Srivastava D; Bradner JE; McKinsey TA; Haldar SM
Sci Transl Med; 2017 May; 9(390):. PubMed ID: 28515341
[TBL] [Abstract][Full Text] [Related]
2. BET bromodomains mediate transcriptional pause release in heart failure.
Anand P; Brown JD; Lin CY; Qi J; Zhang R; Artero PC; Alaiti MA; Bullard J; Alazem K; Margulies KB; Cappola TP; Lemieux M; Plutzky J; Bradner JE; Haldar SM
Cell; 2013 Aug; 154(3):569-82. PubMed ID: 23911322
[TBL] [Abstract][Full Text] [Related]
3. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA
Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188
[TBL] [Abstract][Full Text] [Related]
4. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
5. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
[TBL] [Abstract][Full Text] [Related]
6. BET acetyl-lysine binding proteins control pathological cardiac hypertrophy.
Spiltoir JI; Stratton MS; Cavasin MA; Demos-Davies K; Reid BG; Qi J; Bradner JE; McKinsey TA
J Mol Cell Cardiol; 2013 Oct; 63():175-9. PubMed ID: 23939492
[TBL] [Abstract][Full Text] [Related]
7. BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy.
Antolic A; Wakimoto H; Jiao Z; Gorham JM; DePalma SR; Lemieux ME; Conner DA; Lee DY; Qi J; Seidman JG; Bradner JE; Brown JD; Haldar SM; Seidman CE; Burke MA
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32603312
[TBL] [Abstract][Full Text] [Related]
8. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.
Belkina AC; Nikolajczyk BS; Denis GV
J Immunol; 2013 Apr; 190(7):3670-8. PubMed ID: 23420887
[TBL] [Abstract][Full Text] [Related]
9. BET-inhibition by JQ1 alleviates streptozotocin-induced diabetic cardiomyopathy.
Guo M; Wang HX; Chen WJ
Toxicol Appl Pharmacol; 2018 Aug; 352():9-18. PubMed ID: 29782963
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Reader BRD4 (Bromodomain-Containing Protein 4) Governs Nucleus-Encoded Mitochondrial Transcriptome to Regulate Cardiac Function.
Kim SY; Zhang X; Schiattarella GG; Altamirano F; Ramos TAR; French KM; Jiang N; Szweda PA; Evers BM; May HI; Luo X; Li H; Szweda LI; Maracaja-Coutinho V; Lavandero S; Gillette TG; Hill JA
Circulation; 2020 Dec; 142(24):2356-2370. PubMed ID: 33113340
[TBL] [Abstract][Full Text] [Related]
11. Paeoniflorin attenuates pressure overload-induced cardiac remodeling via inhibition of TGFβ/Smads and NF-κB pathways.
Zhou H; Yang HX; Yuan Y; Deng W; Zhang JY; Bian ZY; Zong J; Dai J; Tang QZ
J Mol Histol; 2013 Jun; 44(3):357-67. PubMed ID: 23417833
[TBL] [Abstract][Full Text] [Related]
12. BET Protein-Mediated Transcriptional Regulation in Heart Failure.
Ijaz T; Burke MA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199719
[TBL] [Abstract][Full Text] [Related]
13. BET bromodomain-containing epigenetic reader proteins regulate vascular smooth muscle cell proliferation and neointima formation.
Dutzmann J; Haertlé M; Daniel JM; Kloss F; Musmann RJ; Kalies K; Knöpp K; Pilowski C; Sirisko M; Sieweke JT; Bauersachs J; Sedding DG; Gegel S
Cardiovasc Res; 2021 Feb; 117(3):850-862. PubMed ID: 32353113
[TBL] [Abstract][Full Text] [Related]
14. Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure.
Nomura S; Satoh M; Fujita T; Higo T; Sumida T; Ko T; Yamaguchi T; Tobita T; Naito AT; Ito M; Fujita K; Harada M; Toko H; Kobayashi Y; Ito K; Takimoto E; Akazawa H; Morita H; Aburatani H; Komuro I
Nat Commun; 2018 Oct; 9(1):4435. PubMed ID: 30375404
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure.
Gesmundo I; Miragoli M; Carullo P; Trovato L; Larcher V; Di Pasquale E; Brancaccio M; Mazzola M; Villanova T; Sorge M; Taliano M; Gallo MP; Alloatti G; Penna C; Hare JM; Ghigo E; Schally AV; Condorelli G; Granata R
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):12033-12038. PubMed ID: 29078377
[TBL] [Abstract][Full Text] [Related]
16. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma.
Song S; Li Y; Xu Y; Ma L; Pool Pizzi M; Jin J; Scott AW; Huo L; Wang Y; Lee JH; Bhutani MS; Weston B; Shanbhag ND; Johnson RL; Ajani JA
Mol Oncol; 2020 Jun; 14(6):1410-1426. PubMed ID: 32175692
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage.
Suarez-Alvarez B; Morgado-Pascual JL; Rayego-Mateos S; Rodriguez RM; Rodrigues-Diez R; Cannata-Ortiz P; Sanz AB; Egido J; Tharaux PL; Ortiz A; Lopez-Larrea C; Ruiz-Ortega M
J Am Soc Nephrol; 2017 Feb; 28(2):504-519. PubMed ID: 27436852
[TBL] [Abstract][Full Text] [Related]
18. BET bromodomain inhibition of MYC-amplified medulloblastoma.
Bandopadhayay P; Bergthold G; Nguyen B; Schubert S; Gholamin S; Tang Y; Bolin S; Schumacher SE; Zeid R; Masoud S; Yu F; Vue N; Gibson WJ; Paolella BR; Mitra SS; Cheshier SH; Qi J; Liu KW; Wechsler-Reya R; Weiss WA; Swartling FJ; Kieran MW; Bradner JE; Beroukhim R; Cho YJ
Clin Cancer Res; 2014 Feb; 20(4):912-25. PubMed ID: 24297863
[TBL] [Abstract][Full Text] [Related]
19. SAA1 deficiency alleviates cardiac remodeling by inhibiting NF-κB/p38/JNK and TGFβ/Smad pathways.
Xiao Y; Ni L; Shi H; Yang K; Yang J; Zhao J; Liu J; Luo P
FASEB J; 2023 May; 37(5):e22911. PubMed ID: 37022639
[TBL] [Abstract][Full Text] [Related]
20. BRD4 (Bromodomain-Containing Protein 4) Interacts with GATA4 (GATA Binding Protein 4) to Govern Mitochondrial Homeostasis in Adult Cardiomyocytes.
Padmanabhan A; Alexanian M; Linares-Saldana R; González-Terán B; Andreoletti G; Huang Y; Connolly AJ; Kim W; Hsu A; Duan Q; Winchester SAB; Felix F; Perez-Bermejo JA; Wang Q; Li L; Shah PP; Haldar SM; Jain R; Srivastava D
Circulation; 2020 Dec; 142(24):2338-2355. PubMed ID: 33094644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
